A detailed history of Horizon Investments, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Horizon Investments, LLC holds 29,916 shares of HRMY stock, worth $1.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,916
Previous 15,366 94.69%
Holding current value
$1.02 Million
Previous $485,000 69.9%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$26.76 - $38.05 $389,358 - $553,627
14,550 Added 94.69%
29,916 $824,000
Q2 2025

Aug 13, 2025

BUY
$27.94 - $35.91 $429,326 - $551,793
15,366 New
15,366 $485,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.01B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.